The main project of my PhD 🧬🔬 is out: we developed single-cell lentiMPRA, a lentivirus-based method to measure enhancer activity and transcriptomes at single-cell resolution. We then applied sc-lentiMPRA to fully synthetic enhancers 🧩...
🔗 doi.org/10.64898/202...
04.03.2026 10:25 —
👍 37
🔁 10
💬 3
📌 3
Proud of @juruehle.bsky.social for getting her PhD paper on biorxiv! In it, we take synthetic enhancer screens to the single cell level, offering new insight into how transcription factors and enhancers interact 👀
04.03.2026 11:31 —
👍 15
🔁 4
💬 0
📌 0
Early bird registration is closing Feb 28! We will have an AMAZING party!
17.02.2026 15:14 —
👍 2
🔁 3
💬 0
📌 0
La investigación del cáncer en 2025 | Contra el Cáncer
Descubre los proyectos y avances clave en investigación contra el cáncer que cuentan con el apoyo de la Asociación Española Contra el Cáncer en 2025
Una buena noticia para empezar el año 😊 El trabajo liderado por @larsplus.bsky.social, investigador del CRG, ha sido reconocido por la Asociación Española contra el Cáncer como uno de los avances de investigación más destacados de 2025.
12.01.2026 08:56 —
👍 3
🔁 1
💬 0
📌 0
ONLINE FIRST ALERT!
Molecular #Plasticity Results in #Oncofetal #Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia
aacrjournals.org/bloodcancerd...
@aacrjournals.bsky.social
#childhoodcancer
#epigenetics
#precisiononcology
06.12.2025 00:58 —
👍 21
🔁 6
💬 3
📌 2
Do not miss this conference!
05.12.2025 11:36 —
👍 1
🔁 0
💬 0
📌 0
If you are thinking where to do your Postdoc, I can only give my highest recommendations to join Lars and his team!
20.11.2025 09:58 —
👍 3
🔁 0
💬 0
📌 0
GitHub - hadley/genzplyr: dplyr but make it bussin fr fr no cap
dplyr but make it bussin fr fr no cap. Contribute to hadley/genzplyr development by creating an account on GitHub.
Do you teach #rstats? Do your students complain about how lame and old-fashioned dplyr is? Don't worry: I have the solution for you: github.com/hadley/genzp....
genzplyr is dplyr, but bussin fr fr no cap.
06.11.2025 23:25 —
👍 460
🔁 167
💬 42
📌 55
🚀 Thinking about your next big career step in science?
The Int'l PhD Program at DKFZ could be a perfect fit for you.
🌍 Work in an international environment, with 500+ doctoral researchers
🔬 Do cutting-edge cancer research
Curious? Join our online info session on 20 Nov. Register here: t1p.de/ws7q3
05.11.2025 09:57 —
👍 9
🔁 10
💬 0
📌 2
This was a lot of fun! Thanks Daylon and @arunsharmaphd.bsky.social for being great hosts!
18.09.2025 10:09 —
👍 5
🔁 2
💬 0
📌 0
Enjoy the videos and music that you love, upload original content and share it all with friends, family and the world on YouTube.
#IRBBarcelona & @crg.eu scientists identify DNA “barcodes” that mark blood cell #aging—accelerating after 50. Published in @nature.com, the work could pave the way for preventive, personalized #antiaging therapies.
https://youtu.be/ST5YmqqMcuQ
@alejofraticelli.bsky.social
#AgingResearch
🧪
12.08.2025 09:03 —
👍 13
🔁 5
💬 0
📌 0
Wie Immunzellen kommunizieren, um Krankheiten und Krebs zu bekämpfen
Ein interdisziplinäres Team aus Wissenschaftlerinnen und Wissenschaftlern vom Berlin Institute of Health in der Charité (BIH), vom Max Delbrück Center, dem Deutschen Krebsforschungszentrum (DKFZ), dem...
Ein Team aus Forschenden vom BIH, @mdc-berlin.bsky.social, DKFZ, HI-STEM und @qmul.bsky.social hat eine Technologie zur Entschlüsselung der Immunzell-Kommunikation entwickelt. Damit lässt sich unter anderem ablesen, warum Immuntherapien bei manchen Menschen wirken bei anderen nicht.
t1p.de/w3v16
07.08.2025 12:43 —
👍 4
🔁 4
💬 0
📌 0
Excited to share our latest paper @natmethods.nature.com
We present a high-throughput framework to map cellular interactions at ultra-high scale – broadly applicable from whole-organism immune response mapping to personalized therapy response prediction (1/4).
www.nature.com/articles/s41...
07.08.2025 11:24 —
👍 34
🔁 14
💬 3
📌 0
Integrative spatial and multi-omic profiling in bladder cancer links L1 retrotransposition to extrachromosomal DNA, genomic instability, and viral mimicry response https://www.biorxiv.org/content/10.1101/2025.07.30.667694v1
02.08.2025 07:48 —
👍 1
🔁 2
💬 0
📌 0
Cancer Epigenomics - German Cancer Research Center
Do you want to improve our understanding of therapy resistance induced by epigenetic heterogeneity? Do you have a PhD in Molecular Biology or related fields? Join us as a (fully-funded) Postdoc in the Division of Cancer Epigenomics at DKFZ. More information here: www.dkfz.de/en/cancer-ep...
18.07.2025 06:54 —
👍 3
🔁 0
💬 1
📌 0
DNA demethylation-mediated downregulation of MNX1 in acute myeloid leukemia - Leukemia
Leukemia - DNA demethylation-mediated downregulation of MNX1 in acute myeloid leukemia
In our study published in Leukemia, we showed that HMA treatment can also lead to repression of oncogenes such as MNX1 through the activation of miRNAs. Great work by Simge Kelekci from our division. www.nature.com/articles/s41...
15.07.2025 11:22 —
👍 2
🔁 0
💬 0
📌 0
Out in Leukemia (@natureportfolio.nature.com). Hypomethylating agents (HMAs) such as decitabine are used in clinical practice for the treatment of Acute Myeloid Leukemia and expected to re-activate tumor suppressor genes de-activated by aberrant DNA methylation.
15.07.2025 11:22 —
👍 2
🔁 0
💬 1
📌 0
The next #ScienceatDKFZ event will take place on Monday, 23 June 2025, at 4 pm. In addition to the keynote lecture by Chong Sun, there will be four 5-minute short talks by DKFZ junior scientists on recent highlight publications.
➡️ dkfz.de/en/news/even...
20.06.2025 07:40 —
👍 4
🔁 1
💬 0
📌 0
The genetic architecture of an allosteric hormone receptor
Many proteins function as switches, detecting chemicals and transducing their concentrations into cellular responses. Receptor switches are key to the integration of environmental signals, yet it is n...
1 plant hormone receptor ☘️
3,500 mutants, to single-site saturation 🧬
>45,000 binding and abundance measurements 📶
Very happy to present our latest work – where deep mutational scanning meets the world of small molecules.
www.biorxiv.org/content/10.1...
With @benlehner.bsky.social
[1/7]
02.06.2025 13:36 —
👍 49
🔁 23
💬 3
📌 0
15,8 Millionen Euro für neuen Sonderforschungsbereich zu Blutkrebs
Die Deutsche Forschungsgemeinschaft (DFG) unterstützt in den kommenden vier Jahren den neuen Sonderforschungsbereich (SFB) 1709 „Zelluläre Plastizität in malignen myeloischen Erkrankungen – Vom Mechan...
📢Die @dfg.de unterstützt in den kommenden vier Jahren den neuen Sonderforschungsbereich „Zelluläre Plastizität in malignen myeloischen Erkrankungen – Vom Mechanismus zur Therapie“ der Medizinischen Fakultät Heidelberg mit rund 15,8 Mio. Euro.
➡️ t1p.de/rpslw
30.05.2025 08:18 —
👍 10
🔁 3
💬 0
📌 0
The fantastic lineup for our latest webinar series, Unlocking the Epigenome: Precision Tools for Complex Diseases, includes: @chiaraherzog.bsky.social, @a-radzisheuskaya.bsky.social, @sankarinagarajan.bsky.social, @sebpreissl.bsky.social, @scherermich.bsky.social, and more! Check them out below!
29.05.2025 12:01 —
👍 2
🔁 3
💬 0
📌 0
Tracing human clones and lineages with DNA methylation. Congratulations for this fascinating breakthrough!
26.05.2025 18:38 —
👍 6
🔁 1
💬 1
📌 0